MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced it has granted an exclusive global license to Asia Biotech Corporation for the development of non-prescription dietary food supplements, nutraceuticals and cosmetics containing Geron’s small molecule telomerase activating compounds. Terms of the license were not disclosed.
